Reduced/VBN
susceptibility/NN
to/TO
HIV-1/NN
infection/NN
of/IN
ethyl-methanesulfonate-treated/JJ
CEM/NN
subclones/NNS
correlates/VBZ
with/IN
a/DT
blockade/NN
in/IN
their/PRP$
protein/NN
kinase/NN
C/NN
signaling/NN
pathway/NN
./.

We/PRP
have/VBP
described/VBN
the/DT
isolation/NN
of/IN
chemically/RB
induced/VBN
CEM/NN
subclones/NNS
that/WDT
express/VBP
CD4/NN
receptors/NNS
and/CC
bind/VBP
soluble/JJ
gp120/NN
,/,
yet/RB
show/VBP
a/DT
markedly/RB
reduced/VBN
susceptibility/NN
to/TO
infection/NN
with/IN
HIV-1/NN
./.
=====
Two/CD
subclones/NNS
were/VBD
found/VBN
to/TO
have/VB
an/DT
abnormal/JJ
response/NN
to/TO
the/DT
protein/NN
kinase/NN
C/NN
(/(
PKC/NN
)/)
activator/NN
PMA/NN
./.
=====
PMA/NN
treatment/NN
induced/VBD
CD3/NN
and/CC
CD25/NN
(/(
IL-2R/NN
)/)
receptors/NNS
on/IN
the/DT
parental/JJ
line/NN
and/CC
on/IN
other/JJ
ethyl-methanesulfonate-derived/JJ
subclones/NNS
,/,
but/CC
not/RB
on/IN
these/DT
two/CD
mutants/NNS
./.
=====
Direct/JJ
assays/NNS
of/IN
PKC/NN
activity/NN
were/VBD
conducted/VBN
./.
=====
Total/JJ
cellular/JJ
PKC/NN
enzymatic/JJ
activity/NN
was/VBD
found/VBN
to/TO
be/VB
normal/JJ
in/IN
these/DT
subclones/NNS
./.
=====
PMA-induced/JJ
CD4/NN
down-modulation/NN
occurred/VBD
normally/RB
./.
=====
In/IN
addition/NN
,/,
activation/NN
of/IN
c-raf/NN
kinase/NN
was/VBD
normal/JJ
./.
=====
Since/IN
HIV-1/NN
long/JJ
terminal/JJ
repeat/NN
contains/VBZ
two/CD
functional/JJ
nuclear/JJ
factor/NN
kB/NN
(/(
NF-kB/NN
)/)
regulatory/JJ
elements/NNS
,/,
we/PRP
studied/VBD
the/DT
ability/NN
of/IN
PMA/NN
to/TO
induce/VB
NF-kB/NN
binding/NN
activity/NN
by/IN
different/JJ
assays/NNS
./.
=====
Chloramphenicol/NN
acetyl/NN
transferase/NN
(/(
CAT/NN
)/)
assays/NNS
using/VBG
the/DT
HIV-1/NN
(/(
-139/CD
)/)
long/JJ
terminal/JJ
repeat-CAT/JJ
construct/NN
showed/VBD
no/DT
PMA/NN
induction/NN
of/IN
CAT/NN
activity/NN
in/IN
these/DT
subclones/NNS
(/(
unlike/IN
the/DT
parental/JJ
line/NN
and/CC
other/JJ
subclones/NNS
)/)
./.
=====
Okadaic/JJ
acid/NN
,/,
an/DT
inhibitor/NN
of/IN
phosphatases/NNS
1/CD
and/CC
2A/NN
,/,
did/VBD
not/RB
overcome/VB
the/DT
defect/NN
in/IN
these/DT
subclones/NNS
./.
=====
Gel/NN
retardation/NN
assays/NNS
,/,
using/VBG
a/DT
32P-probe/NN
containing/VBG
the/DT
HIV-1/NN
NF-kB/NN
probe/NN
and/CC
nuclear/JJ
extracts/NNS
from/IN
PMA-treated/JJ
cells/NNS
,/,
showed/VBD
significantly/RB
reduced/VBN
induction/NN
of/IN
nuclear/JJ
NF-kB/NN
binding/NN
proteins/NNS
in/IN
these/DT
two/CD
subclones/NNS
compared/VBN
with/IN
wild/JJ
type/NN
CEM/NN
and/CC
a/DT
control/NN
subclone/NN
./.
=====
Deoxycholate/JJ
treatment/NN
of/IN
cytoplasmic/JJ
extracts/NNS
from/IN
these/DT
subclones/NNS
released/VBD
much/JJ
reduced/VBN
NF-kB/NN
binding/NN
proteins/NNS
from/IN
their/PRP$
cytoplasmic/JJ
pools/NNS
./.
=====
Thus/RB
,/,
reduced/JJ
levels/NNS
of/IN
PKC-induced/JJ
nuclear/JJ
NF-kB/NN
activity/NN
in/IN
two/CD
T/NN
cell/NN
subclones/NNS
did/VBD
not/RB
affect/VB
their/PRP$
normal/JJ
cell/NN
growth/NN
,/,
but/CC
correlated/VBD
with/IN
a/DT
pronounced/JJ
reduction/NN
in/IN
their/PRP$
susceptibility/NN
to/TO
HIV-1/NN
infection/NN
./.